isoxazoles has been researched along with Smoking Cessation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kittakoop, P; Mahidol, C; Ruchirawat, S | 1 |
| Dunn, KE; Kim, C; Marcus, TF; Schroeder, JR; Umbricht, A; Vandrey, R | 1 |
1 review(s) available for isoxazoles and Smoking Cessation
| Article | Year |
|---|---|
Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Antitubercular Agents; Humans; Isoxazoles; Molecular Structure; Pyridines; Quinazolines; Smoking Cessation | 2014 |
1 trial(s) available for isoxazoles and Smoking Cessation
| Article | Year |
|---|---|
Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.
Topics: Adult; Humans; Isoxazoles; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Zonisamide | 2016 |